|
Journal Papers, Abstracts, and Commentaries
| |
|
Vitamin D Levels and Markers of Arterial
Dysfunction in HIV.
Shikuma C, Seto T, Liang CY, Bennett K, et al
AIDS Res Hum Retroviruses.
2011 Oct
.
Abstract
Avascular necrosis in HIV.
Mehta P, Nelson M, Brand A, Boag F.
Rheumatol Int. 2011 Sep 22
Abstract
Progressive human immunodeficiency virus-associated vasculopathy:
time to revise antiretroviral
therapy guidelines?
Ntusi NB, Taylor D, Naidoo NG, Mendelson M.
Cardiovasc J Afr.
2011 Jul-Aug;22(4):197-200.
Abstract
Immune Dysregulation and Vascular Risk in
HIV-Infected Patients: Implications for Clinical Care.
Triant VA, Grinspoon SK.
J Infect Dis.
2011 Jan 10.
Abstract |
Relationship of Body Composition, Metabolic Status,
Antiretroviral Use, and HIV
Disease Factors to Endothelial Dysfunction in HIV-Infected
Subjects.
Dubé MP, Shen C, Mather KJ, et al
AIDS Res Hum Retroviruses.
2010 Aug 1
Abstract |
Untreated HIV infection and large and small artery
elasticity.
Baker JV, Duprez D, Rapkin J,
et al
J Acquir Immune Defic Syndr. 2009
Sep 1;52(1):25-31.
Abstract |
Relationship
between ankle-brachial index and carotid intima-media thickness in
HIV-infected patients.
Gutiérrez F, Bernal E, Padilla S, et al
AIDS. 2008 Jul 11;22(11):1369-71
Abstract
|
Vascular surgical complications of the acquired immunodeficiency syndrome.
Woolgar JD, Robbs JV.
Eur J Vasc Endovasc Surg 2002 Dec;24(6):473-9
Abstract
|
|
|
|
Conference Reports, Abstracts, and Posters
| |
POSTER
Does Rosiglitazone Alter Vascular Function in Patients with HIV
Lipoatrophy?
A Martin, J Kovacic, D Carey,et al.
(11 CROI)
 PDF
Poster
Abstract |
|
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
| |
Effects of Lifestyle Modification and Metformin on
Atherosclerotic Indices among HIV-Infected
Patients with the Metabolic Syndrome.
Fitch K, Abbara S, Lee H,
et al
AIDS. 2011 Nov 22.
Abstract
Incipient Renal Impairment as a Predictor of Subclinical
Atherosclerosis in
HIV Infected Patients.
Serrano-Villar S, Estrada V, Gómez-Garre D,
et al
J Acquir Immune Defic Syndr.
2011 Nov 20
Abstract
Noninvasive Coronary Imaging for Atherosclerosis in
Human Immunodeficiency Virus Infection.
Gharib AM, Abd-Elmoniem KZ, Pettigrew RI, Hadigan C.
Curr Probl Diagn Radiol.
2011 November - December;40(6):262-267.
Abstract
Low plasma levels of the soluble receptor for
advanced glycation end products in HIV-infected patients
with subclinical
carotid atherosclerosis receiving combined
antiretroviral therapy.
Jeong SJ, Kim CO, Song YG,
et al
Atherosclerosis.
2011 Aug 10.
Abstract
HIV Infection and Progression of Carotid and Coronary
Atherosclerosis:
The CARE Study.
A M, Jf P, S S,
et
al
J Acquir Immune Defic Syndr.
2011 Jul 22
Abstract
Comparison of intima-media thickness and ophthalmic artery
resistance index for assessing
subclinical atherosclerosis in HIV-1-infected patients.
Grima P, Guido M, Chiavaroli R, et al
Cardiovasc Ultrasound.
2011 Apr 1;9(1):9.
Abstract
Markers of atherosclerosis and inflammation and mortality in
patients with
HIV infection.
Mangili A, Polak JF, Quach LA, et al
Atherosclerosis.
2010 Nov 17
Abstract |
Pharmacogenetics of the Metabolic Disturbances and
Atherosclerosis Associated with
Antiretroviral Therapy in HIV-Infected Patients.
Veloso S, Peraire J, Viladés C, et al
Curr Pharm Des.
2010 Aug 5
Abstract |
Micronutrient concentrations and subclinical
atherosclerosis in adults with HIV.
Falcone EL, Mangili A, Tang AM,
et al
Am J Clin Nutr. 2010 Mar 10
Abstract |
Increased prevalence of subclinical coronary atherosclerosis
detected by coronary
computed tomography angiography in HIV-infected men.
Lo J, Abbara S, Shturman L, et al
AIDS.
2009 Dec 7
Abstract |
The macrophage: the intersection between HIV
infection and atherosclerosis.
Crowe SM, Westhorpe CL, Mukhamedova N, et al
J Leukocyte Biol.
2009 Dec 1
Abstract |
HIV positivity, protease inhibitor exposure, and subclinical
atherosclerosis:
A systematic review and meta-analysis of observational
studies.
Hulten E, Mitchell J, Scally J, Gibbs B, Villines T.
Heart.
2009 Jul 23.
Abstract |
Lipodystrophy and anti-retroviral therapy as predictors of
sub-clinical atherosclerosis
in human immunodeficiency virus infected subjects.
Guaraldi G, Stentarelli C, Zona S, et al
Atherosclerosis. 2009 Jun 18.
Abstract |
Preclinical atherosclerosis due to HIV infection: carotid intima-medial
thickness
measurements
from the FRAM study.
Grunfeld C, Delaney JA, Wanke C, et al
AIDS. 2009
May 18
Abstract |
Prevention of atherosclerosis in patients living
with HIV.
De Lorenzo F, Boffito M, Collot-Teixeira S, et al
Vasc Health Risk Manag.
2009;5(1):287-300.
Abstract |
Metabolic-Inflammatory Changes, and Accelerated Atherosclerosis in
HIV Patients:
Rationale for Preventative Measures.
De Lorenzo F, Collot-Teixeira S, et al
Curr Med Chem.
2008;15(28):2991
Abstract
|
Carotid Intima-Media Thickness in Heavily Pretreated HIV-Infected Patients.
Chironi G, Escaut L, Gariepy J, et al.
J Acquir Immune Defic Syndr 2003 Apr
15;32(5):490-493
Abstract
FULL-TEXT ARTICLE
HIV protease
inhibitors and atherosclerosis
Hui DY
J. Clin. Invest. 111:389-397 (2003)
Paper
FULL-TEXT ARTICLE
HIV protease inhibitors promote atherosclerotic
lesion formation
independent of dyslipidemia
by increasing CD36-dependent cholesteryl ester accumulation in macrophages.
Dressman J, Kincer J, Matveev SV, et al.
J Clin Invest 2003 Feb;111(3):389-97
Paper
Pilot study of coronary atherosclerotic risk
and plaque burden in HIV
patients: 'a call for
cardiovascular prevention'.
Acevedo M, Sprecher DL,
Calabrese L, et al.
Atherosclerosis 2002
Aug;163(2):349-54
Abstract |
|
Conference Reports, Abstracts, and Posters
| |
POSTER
Metabolic syndrome and
subclinic atherosclerosis disease in HIV-infected patients
E. Bernal, A. Muñoz, I. Marín, et al
(6th IAS Conference)
Poster
Abstract
POSTER
Subclinical atherosclerosis
progression among HIV-infected patients: preliminary results
from a 3 years prospective cohort study
P.S. Velli, L. Ibañez, J. Royo, et al
(6th IAS Conference)
Poster
Abstract
POSTER
Correlation between HIV-1,
recombinant gp120, and human vessel wall derived mesenchymal stem
cells:
a new role in adipogenesis induction and atherosclerotic degeneration
M. Borderi, D. Gibellini, V. Colangeli, et al
(6th IAS Conference)
Poster
Abstract
Critical role
of calnexin in Nef-mediated inactivation of ABCA1
L. Jennelle, T. Pushkarsky, M. Bukrinsky, et al
(6th IAS Conference)
Abstract
HIV-RNA
levels are associated with changes in mean platelet volume during the
asymtomatic
HIV-infection in treatment-naïve patients
Á. Mena, H. Meijide, P. Vázquez, et al
(6th IAS Conference)
Abstract
POSTER
Role
of ART, Viral Replication, and HIV
Infection in Atherosclerosis
P Hsu, P Hunt, J
Martin, et al
(15th CROI)
PDF
Poster
Abstract
( |
POSTER
Long Term HIV Infection as an Independent Risk Factor for Early
Atherosclerosis
C Stephan, A Carlebach, A Haberl, et al
(13
CROI)
PDF Poster
Abstract |
Predictors of Atherosclerosis as Measured by Carotid Intima-Media
Thickness in
Non-Smoking
HIV Patients
A. LEBECH, N. WIINBERG , J. GERSTOFT , et al
(45 ICAAC)
Abstract |
Journal Papers, Abstracts, and
Commentaries
Journal Papers, Abstracts, and Commentaries
|
HIV
Cardiovascular Main Page
